Cargando…

A Case of Lung Adenocarcinoma with Long-Term Response after Late-Onset Pembrolizumab-Induced Acute Adrenal Insufficiency

Pembrolizumab is an anti-programmed cell death protein-1 antibody that is mainly used for the treatment of non-small cell lung cancer (NSCLC). Immune-related adverse events can be caused by immune checkpoint inhibitors; however, few case reports evaluate the prognosis of patients with NSCLC with lat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sonehara, Kei, Tateishi, Kazunari, Hirabayashi, Taro, Araki, Taisuke, Ikuyama, Yuichi, Machida, Ryosuke, Hanaoka, Masayuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879310/ https://www.ncbi.nlm.nih.gov/pubmed/33613234 http://dx.doi.org/10.1159/000508068

Ejemplares similares

Pembrolizumab-Induced Adrenal Insufficiency in Patients with Untreated Advanced Non-Small Cell Lung Cancer: A Case Series
por: Sonehara, Kei, et al.
Publicado: (2021)

Prognostic value of the geriatric nutritional risk index among patients with previously treated advanced non‐small cell lung cancer who subsequently underwent immunotherapy
por: Sonehara, Kei, et al.
Publicado: (2021)

Predictive Factors Correlated with the Development of Immune-Related Adverse Events in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors
por: Sonehara, Kei, et al.
Publicado: (2022)

Association of lung immune prognostic index with survival outcome in advanced thymic carcinoma patients treated with palliative intent chemotherapy
por: Araki, Taisuke, et al.
Publicado: (2022)

Pulmonary Spindle Cell Carcinoma Presenting Anaplastic Lymphoma Kinase Rearrangement
por: Sonehara, Kei, et al.
Publicado: (2023)

Prognostic implication of erector spinae muscles in non‐small‐cell lung cancer patients treated with immuno‐oncology combinatorial chemotherapy
por: Araki, Taisuke, et al.
Publicado: (2021)

Rothia aeria pneumonia in an immunocompetent patient: A novel case study
por: Sonehara, Kei, et al.
Publicado: (2021)

Prognosis of patients with acute exacerbation of combined pulmonary fibrosis and emphysema: a retrospective single-centre study
por: Ikuyama, Yuichi, et al.
Publicado: (2020)

Clinical utility of the C‐reactive protein:albumin ratio in non‐small cell lung cancer patients treated with nivolumab
por: Araki, Taisuke, et al.
Publicado: (2021)

Lung immune prognostic index as a prognostic factor in patients with small cell lung cancer
por: Sonehara, Kei, et al.
Publicado: (2020)

C‐PLAN index as a prognostic factor for patients with previously untreated advanced non‐small cell lung cancer who received combination immunotherapy: A multicenter retrospective study
por: Sonehara, Kei, et al.
Publicado: (2023)

Usual Interstitial Pneumonia Pattern Interstitial Lung Disease Developed in a Patient with IgG4-related Chronic Sclerosing Sialadenitis
por: Yamamoto, Hiroshi, et al.
Publicado: (2022)

The efficacy of amrubicin third‐line chemotherapy in patients with relapsed extensive‐disease small‐cell lung cancer: A retrospective and historical study in a single institute
por: Sonehara, Kei, et al.
Publicado: (2019)

Acute Kidney Injury after Pembrolizumab-Induced Adrenalitis and Adrenal Insufficiency
por: Hanna, Ramy M., et al.
Publicado: (2018)

Two Cases of Pembrolizumab-Induced Secondary Adrenal Insufficiency
por: Kanzaki, Akinori, et al.
Publicado: (2021)

Obstructive Pneumonia Associated with Endobronchial Aspergilloma: Successful Treatment with Interventional Bronchoscopy and Antifungals
por: Komatsu, Masamichi, et al.
Publicado: (2022)

Cardiac tamponade and adrenal insufficiency due to pembrolizumab: a case report
por: Oristrell, Gerard, et al.
Publicado: (2018)

Predictive value of post‐treatment C‐reactive protein‐to‐albumin ratio in locally advanced non–small cell lung cancer patients receiving durvalumab after chemoradiotherapy
por: Araki, Taisuke, et al.
Publicado: (2022)

Pembrolizumab-Induced Adrenal Insufficiency Presenting Eight Months After Cessation of Treatment
por: Zilberman, Stephanie, et al.
Publicado: (2023)

Successful recovery from critical COVID-19 pneumonia with extracorporeal membrane oxygenation: A case report
por: Ikuyama, Yuichi, et al.
Publicado: (2020)

Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non‐small‐cell lung cancer
por: Kurokawa, Kana, et al.
Publicado: (2022)

Brain ultrasonographic findings of late-onset circulatory dysfunction due to adrenal insufficiency in preterm infants
por: Shin, Su-Mi, et al.
Publicado: (2016)

A Case of Nonsmall-Cell Lung Cancer with Anaphylaxis after 41 Courses of Pembrolizumab along with Adrenal Insufficiency as an Immune-Related Adverse Event
por: Nakamura, Tomoaki, et al.
Publicado: (2022)

Autoimmune Myasthenia, Primary Adrenal Insufficiency, and Progressive Hypothyroidism Due to Pembrolizumab and Axitinib Combination Regimen
por: Figueroa-Perez, Nikole, et al.
Publicado: (2021)

Simultaneous Presentation of Secondary Adrenal Insufficiency and Primary Hypothyroidism due to Pembrolizumab: A Case Report
por: Khatri, Shivam, et al.
Publicado: (2023)

MON-256 A Late-Onset Case of Sheehan’s Syndrome Presenting as Life Threatening Adrenal Insufficiency
por: Bhat, Salman Zahoor, et al.
Publicado: (2020)

LBODP011 Pembrolizumab Induced Hypophysitis And Resultant Isolated ACTH Deficiency Presenting As Secondary Adrenal Insufficiency.
por: Arora, Gunjan, et al.
Publicado: (2022)

FRI253 Concurrent Adrenal Insufficiency And Hyperthyroidism In A Breast Cancer Patient Treated With Pembrolizumab Therapy
por: Kulkarni, Abhigna U, et al.
Publicado: (2023)

Rechallenge of afatinib for EGFR-mutated non-small cell lung cancer previously treated with osimertinib: a multicenter phase II trial protocol (REAL study)
por: Araki, Taisuke, et al.
Publicado: (2023)

Late-onset transient adrenal insufficiency in preterm twins with twin-to-twin transfusion syndrome: A case report
por: Ho, Chin Yee, et al.
Publicado: (2017)

FRI225 Clinical Course Of Late-onset Adrenal Insufficiency Due To Treatment Of Childhood Acute Lymphoblastic Leukemia
por: Iwabuchi, Masayasu
Publicado: (2023)

New onset adrenal insufficiency in a patient with COVID-19
por: Hashim, Maram, et al.
Publicado: (2021)

Adrenal Insufficiency
por: Marik, Paul Ellis
Publicado: (2014)

Successful Rescue of Life-threatening Hemoptysis Caused by Pulmonary Tuberculosis Bridging with Extracorporeal Membrane Oxygenation
por: Araki, Taisuke, et al.
Publicado: (2022)

SUN-276 Pembrolizumab-Induced Secondary Adrenal Insufficiency Presenting as Severe Hyponatremia in an 80-Year-Old Male
por: Kawaji, Leslie Daphne R, et al.
Publicado: (2020)

Late onset adrenal insufficiency after adrenalectomy due to latent nonclassical 21-hydroxylase deficiency: A case report
por: Hirai, Hiroyuki, et al.
Publicado: (2018)

Late‐onset acute type 1 diabetes mellitus 7 months after discontinuation of pembrolizumab against lung cancer
por: Ichihara, Seiya, et al.
Publicado: (2022)

Primary Adrenal Insufficiency due to Cryptococcus With Persistent Adrenal Enlargement and Insufficiency
por: Price, Catherine E., et al.
Publicado: (2023)

Evolving adrenal insufficiency
por: Roy, Ajitesh, et al.
Publicado: (2012)

Adrenal Insufficiency and CIRCI
por: Marik, Paul Ellis
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_uef0ik94p7oo2n02epovk75ptf